Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2025-12-25 @ 2:51 AM
NCT ID:
NCT00316433
Eligibility Criteria:
Inclusion Criteria:
* Previously untreated extensive small cell lung cancer
* No prior chemotherapy
* No prior radiotherapy except for the treatment of brain metastases
Exclusion Criteria:
* Prior treatment for extensive stage small cell lung cancer
* Known hypersensitivity to any of the components of oxaliplatin or CPT-11
* Greater than grade 2 peripheral neuropathy
* Known HIV or Hepatitis B or C (active, previously treated or both)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00316433
Study Brief:
Protocol Section:
NCT00316433